SaNOtize has raised a $24 million series B round, giving it the cash to fund its ongoing phase 3 COVID-19 prevention trial and other research into its nitric oxide nasal spray (NONS). The ...
VANCOUVER, British Columbia & MUMBAI, India--(BUSINESS WIRE)--SaNOtize Research and Development Corp. and Indian company, Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical ...
SAN FRANCISCO and TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (formerly Kalytera Therapeutics, Inc.) (TSX VENTURE: KLY and OTC: KALTF) (the "Company" or "Claritas") ...
As the winter virus season approaches, individuals worldwide search for additional means to protect themselves against respiratory infections, such as COVID-19. In response to the ongoing pandemic, ...
Objectives—To study exhaled nitric oxide (NO) as a marker of airway inflammation caused by potroom exposure, hypothesising that (a) workers exposed to potroom pollutants would have higher ...
Clinically Supported Nasal Care, NOWONDER, Powered by Nitric Oxide Fosters Everyday Defense and Respiratory Health. In a dramatic shift in the way Americans approach everyday hygiene, scientists are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback